Glaxosmithkline Plc Adr Stock Widgets and Gadgets
| GSK Stock | USD 34.33 0.31 0.91% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- GSK GlaxoSmithKline PLC ADR
- Latest ALEC Stock Tanks as Alzheimers Drug Fails in Mid-Stage Study
- GSK 34.33 0.31
- Low 34.19
- High 34.47
- Alpha -0.4
- Beta 0.28
- Return On Equity 0.22
- Return On Asset 0.0724
- Profit Margin 0.08 %
- Operating Margin 0.08 %
- Current Valuation 85.1 B
- Shares Outstanding 2.04 B
- Shares Owned By Insiders 0.06 %
- Shares Owned By Institutions 15.38 %
- Number Of Shares Shorted 23.52 M
- Price To Earning 11.80 X
- Price To Book 3.98 X
- Price To Sales 2.24 X
- Revenue 30.33 B
- Gross Profit 19.92 B
- EBITDA 9.08 B
- Net Income 5.31 B
- Cash And Equivalents 3.72 B
- Cash Per Share 0.32 X
- Total Debt 18.02 B
- Debt To Equity 0.98 %
- Current Ratio 1.43 X
- Book Value Per Share 3.43 X
- Cash Flow From Operations 6.77 B
- Short Ratio 3.32 X
- Earnings Per Share 1.53 X
- Price To Earnings To Growth 0.77 X
- Target Price 45.95
- Number Of Employees 70.21 K
- Beta 0.33
- Market Capitalization 70.04 B
- Total Asset 59.01 B
- Retained Earnings 7.74 B
- Working Capital (2.42 B)
- Current Asset 16.59 B
- Current Liabilities 13.42 B
- Annual Yield 0.05 %
- Five Year Return 5.32 %
- Net Asset 59.01 B
- Last Dividend Paid 0.61
- Accumulation Distribution 0.0081
- Daily Balance Of Power 1.107143
- Rate Of Daily Change 1.01
- Day Median Price 34.33
- Day Typical Price 34.33
- Market Facilitation Index 0.28
- Price Action Indicator 0.15
- Period Momentum Indicator 0.31
Market Snapshot Widget Example
DAX Index Germany | 19,426 0.85 | |
Taiwan Weighted Taiwan | 22,299 0.16 | |
PSI 20 Stock Portugal | 6,431 0.20 | |
CROBEX Croatia | 3,159 0.26 | |
Budapest SE Hungary | 78,374 0.83 | |
IDX 30 Jakarta Indonesia | 447.75 0.92 | |
ISEQ 20 Price Ireland | 1,594 0.58 | |
NYSE Comp USA | 20,210 0.05 | |
Tel Aviv 35 Israel | 2,260 0.72 | |
Coreshares Index Tracker South Afric | 1,106 1.00 | |
IPC MEXICO Mexico | 49,861 0.05 | |
KL Technology Malaysia | 58.73 1.56 | |
IBEX 35 Index Spain | 11,611 0.27 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,529 0.63 | |
SPASX Dividend Opportunities Australia | 1,696 0.33 | |
HNX 30 Vietnam | 475.80 0.32 | |
Bucharest BET-NG Romania | 1,206 0.2 | |
AMS Small Cap Netherlands | 1,215 3.41 | |
Oslo Exchange Mutual Norway | 1,413 0.06 | |
BEL Small Belgium | 8,045 0.09 | |
Basic Materials Brazil | 5,771 0.17 | |
Swiss Leader Price Switzerland | 1,929 0.49 | |
Fondo Mutuo ETF Chile | 1,362 0.28 | |
Athens General Comp Greece | 1,404 0.01 | |
Stock Exchange Of Thailand | 1,428 0.17 | |
PX Prague Stock Czech Repub | 1,695 0.35 | |
THE PHILIPPINE STOCK Philippines | 6,639 0.96 | |
WIG 30 Poland | 2,801 0.2 | |
BIST Electricity Turkey | 489.17 0.36 |
Investing Ideas
In addition to having GlaxoSmithKline PLC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare GlaxoSmithKline PLC
Compare GlaxoSmithKline PLC To Peers
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline PLC ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.28) | Dividend Share 0.61 | Earnings Share 1.53 | Revenue Per Share 15.38 | Quarterly Revenue Growth (0.02) |
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.